CLINICAL_TRIALS
trial_result
· 2015-02-11
Clinical Trial Update: An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ, NCT01552057) [Phase 3]
Summary
An extension study of duloxetine in fibromyalgia (NCT01621191) has completed in Phase 3, with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED | Results posted: 2015-02-11